Screener
Gyre Therapeutics, Inc. GYRE Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by Gyre Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The source filing: Gyre Therapeutics, Inc.’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 7, 2026, 5:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-340448
FAQ
- What is Gyre Therapeutics, Inc.'s operating lease liabilities (current)?
- Gyre Therapeutics, Inc. (GYRE) reported operating lease liabilities (current) of $1.39M in Q2 2026.
- How has Gyre Therapeutics, Inc.'s operating lease liabilities (current) changed year-over-year?
- Gyre Therapeutics, Inc.'s operating lease liabilities (current) increased by 122.7% year-over-year, from $622K to $1.39M.
- What is the long-term trend for Gyre Therapeutics, Inc.'s operating lease liabilities (current)?
- Over 5 years (2020 to 2025), Gyre Therapeutics, Inc.'s operating lease liabilities (current) has grown at a 11.0% compound annual growth rate (CAGR), from $663K to $1.12M.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.
Ask your AI about Gyre Therapeutics, Inc.'s operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude